Regeneron is a U.S-based global biotech company with headquarters in Tarrytown, New York. The statistic illustrates the operating expenses of Regeneron Pharmaceuticals from 2018 to 2024. In 2024, operating expenses for Regeneron amounted to 10.2 billion U.S. dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Regeneron, & U.S. Securities and Exchange Commission. (February 5, 2025). Regeneron Pharmaceuticals operating expenses from 2018 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/1102018/regeneron-pharmaceuticals-operating-expenses/
Regeneron, und U.S. Securities and Exchange Commission. "Regeneron Pharmaceuticals operating expenses from 2018 to 2024 (in million U.S. dollars)." Chart. February 5, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/1102018/regeneron-pharmaceuticals-operating-expenses/
Regeneron, U.S. Securities and Exchange Commission. (2025). Regeneron Pharmaceuticals operating expenses from 2018 to 2024 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/1102018/regeneron-pharmaceuticals-operating-expenses/
Regeneron, and U.S. Securities and Exchange Commission. "Regeneron Pharmaceuticals Operating Expenses from 2018 to 2024 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 5 Feb 2025, /statistics/1102018/regeneron-pharmaceuticals-operating-expenses/
Regeneron & U.S. Securities and Exchange Commission, Regeneron Pharmaceuticals operating expenses from 2018 to 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1102018/regeneron-pharmaceuticals-operating-expenses/ (last visited July 22, 2026)
Regeneron Pharmaceuticals operating expenses from 2018 to 2024 (in million U.S. dollars) [Graph], Regeneron, & U.S. Securities and Exchange Commission, February 5, 2025. [Online]. Available: /statistics/1102018/regeneron-pharmaceuticals-operating-expenses/
